BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20237670)

  • 1. The UDP-Galp mutase catalyzed isomerization: synthesis and evaluation of 1,4-anhydro-beta-D-galactopyranose and its [2.2.2] methylene homologue.
    Sadeghi-Khomami A; Forcada TJ; Wilson C; Sanders DA; Thomas NR
    Org Biomol Chem; 2010 Apr; 8(7):1596-602. PubMed ID: 20237670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Sinaÿ P; Vincent SP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1123-5. PubMed ID: 16377186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
    Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a carbasugar analogue of a putative intermediate in the UDP-galp-mutase catalyzed isomerization.
    Sadeghi-Khomami A; Blake AJ; Wilson C; Thomas NR
    Org Lett; 2005 Oct; 7(22):4891-4. PubMed ID: 16235915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
    Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
    J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the mechanism of binding of UDP-galactopyranose to UDP-galactopyranose mutase by STD-NMR spectroscopy and molecular modeling.
    Yuan Y; Wen X; Sanders DA; Pinto BM
    Biochemistry; 2005 Nov; 44(43):14080-9. PubMed ID: 16245924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
    Partha SK; van Straaten KE; Sanders DA
    J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UDP-galactopyranose mutase has a novel structure and mechanism.
    Sanders DA; Staines AG; McMahon SA; McNeil MR; Whitfield C; Naismith JH
    Nat Struct Biol; 2001 Oct; 8(10):858-63. PubMed ID: 11573090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
    Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
    Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
    Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
    Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
    Eppe G; Peltier P; Daniellou R; Nugier-Chauvin C; Ferrières V; Vincent SP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):814-6. PubMed ID: 19119008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel ammonium and selenonium ions and their evaluation as inhibitors of UDP-galactopyranose mutase.
    Veerapen N; Yuan Y; Sanders DA; Pinto BM
    Carbohydr Res; 2004 Sep; 339(13):2205-17. PubMed ID: 15337448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
    Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
    J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical probes of UDP-galactopyranose mutase.
    Carlson EE; May JF; Kiessling LL
    Chem Biol; 2006 Aug; 13(8):825-37. PubMed ID: 16931332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tautomerization in the UDP-galactopyranose mutase mechanism: a DFT-cluster and QM/MM investigation.
    Huang W; Gauld JW
    J Phys Chem B; 2012 Dec; 116(48):14040-50. PubMed ID: 23148701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases.
    Bakker H; Kleczka B; Gerardy-Schahn R; Routier FH
    Biol Chem; 2005 Jul; 386(7):657-61. PubMed ID: 16207086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique catalytic mechanism for UDP-galactopyranose mutase.
    Soltero-Higgin M; Carlson EE; Gruber TD; Kiessling LL
    Nat Struct Mol Biol; 2004 Jun; 11(6):539-43. PubMed ID: 15133501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate directs enzyme dynamics by bridging distal sites: UDP-galactopyranose mutase.
    Yao X; Bleile DW; Yuan Y; Chao J; Sarathy KP; Sanders DA; Pinto BM; O'Neill MA
    Proteins; 2009 Mar; 74(4):972-9. PubMed ID: 18767162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and analysis of substrate analogues for UDP-galactopyranose mutase: implication for an oxocarbenium ion intermediate in the catalytic mechanism.
    Itoh K; Huang Z; Liu HW
    Org Lett; 2007 Mar; 9(5):879-82. PubMed ID: 17266324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiometric analysis of UDP-galactopyranose mutase: stabilization of the flavosemiquinone by substrate.
    Fullerton SW; Daff S; Sanders DA; Ingledew WJ; Whitfield C; Chapman SK; Naismith JH
    Biochemistry; 2003 Feb; 42(7):2104-9. PubMed ID: 12590598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.